Acurx Pharmaceuticals annual total assets
2020
2021
2022
2023
2024
2025
Acurx Pharmaceuticals Total Assets Growth & History (ACXP)
Acurx Pharmaceuticals's total assets was $7.7M for fiscal 2025.
View full Acurx Pharmaceuticals company overviewAcurx Pharmaceuticals annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $7.7M | $3.8M | +99.32% |
| 2024 | 2024-12-31 | $3.9M | −$3.9M | −49.96% |
| 2023 | 2023-12-31 | $7.7M | −$1.7M | −17.78% |
| 2022 | 2022-12-31 | $9.4M | −$3.9M | −29.25% |
| 2021 | 2021-12-31 | $13.3M | $10.0M | +311.11% |
| 2020 | 2020-12-31 | $3.2M | — | — |
Acurx Pharmaceuticals quarterly total assets
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $11.0M | $4.8M | +78.39% |
| Q1 2026 | 2026-03-31 | $9.5M | $4.7M | +98.52% |
| Q4 2025 | 2025-12-31 | $7.7M | $3.8M | +99.32% |
| Q3 2025 | 2025-09-30 | $6.1M | $122,452 | +2.05% |
| Q2 2025 | 2025-06-30 | $6.2M | −$422,534 | −6.42% |
| Q1 2025 | 2025-03-31 | $4.8M | −$4.3M | −47.24% |
| Q4 2024 | 2024-12-31 | $3.9M | −$3.9M | −49.96% |
| Q3 2024 | 2024-09-30 | $6.0M | −$1.2M | −16.42% |
| Q2 2024 | 2024-06-30 | $6.6M | −$2.7M | −28.75% |
| Q1 2024 | 2024-03-31 | $9.1M | $1.7M | +23.34% |
| Q4 2023 | 2023-12-31 | $7.7M | −$1.7M | −17.78% |
| Q3 2023 | 2023-09-30 | $7.2M | −$3.8M | −34.60% |
| Q2 2023 | 2023-06-30 | $9.2M | −$23,523 | −0.25% |
| Q1 2023 | 2023-03-31 | $7.4M | −$3.9M | −34.77% |
| Q4 2022 | 2022-12-31 | $9.4M | −$3.9M | −29.25% |
| Q3 2022 | 2022-09-30 | $10.9M | −$4.0M | −26.98% |
| Q2 2022 | 2022-06-30 | $9.3M | −$8.2M | −46.91% |
| Q1 2022 | 2022-03-31 | $11.3M | — | — |
| Q4 2021 | 2021-12-31 | $13.3M | $10.0M | +311.11% |
| Q3 2021 | 2021-09-30 | $15.0M | — | — |
| Q2 2021 | 2021-06-30 | $17.4M | — | — |
| Q4 2020 | 2020-12-31 | $3.2M | — | — |
Acurx Pharmaceuticals total assets trends
Over the last five fiscal years, Acurx Pharmaceuticals's total assets increased from $3.2M to $7.7M, a change of $4.5M. The latest reported quarter, Q2 2026, shows $11.0M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Acurx Pharmaceuticals source filings ↗